약물감시 및 의약품 안전성 소프트웨어 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Pharmacovigilance and Drug Safety Software Market size is expected to reach USD 483.32 Million in 2034 from USD 256.14 Million (2025) growing at a CAGR of 7.31% during 2026-2034.

The global pharmacovigilance and drug safety software market has grown significantly as pharmaceutical companies focus on monitoring drug safety and regulatory compliance. Pharmacovigilance software helps track adverse drug reactions, manage safety data, and ensure compliance with regulatory guidelines throughout the lifecycle of pharmaceutical products.

Several factors are driving the expansion of this market. Increasing drug development activities and stricter regulatory requirements have created demand for advanced safety monitoring systems. Additionally, the growing complexity of clinical trials and post-marketing surveillance programs has encouraged pharmaceutical companies to adopt automated drug safety software solutions.

Looking ahead, the pharmacovigilance and drug safety software market is expected to grow as pharmaceutical companies continue prioritizing patient safety and regulatory compliance. Advances in data analytics and artificial intelligence may improve the ability to detect safety signals and manage large datasets. Furthermore, the expansion of global pharmaceutical markets will likely support continued demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Functionality

• Case Data Collection and Management
• Adverse Event Reporting and Analysis
• Signal Detection and Other Safety Risk Assessment

By Delivery Mode

• On Premise
• On Demand

By End Use

• Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
• CROs/BPOs or PV Service Providers When Outsourced
• Others

COMPANIES PROFILED

• IQVIA, Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM, ArisGlobal, ICON Plc, Capgemini, Oracle, Parexel International Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Functionality
• 4.2. Case Data Collection and Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Adverse Event Reporting and Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Signal Detection and Other Safety Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Delivery Mode
• 5.2. On Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. On Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CROs/BPOs or PV Service Providers When Outsourced Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Functionality
  • 7.2.2 By Delivery Mode
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Functionality
  • 7.3.2 By Delivery Mode
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Functionality
  • 7.4.2 By Delivery Mode
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Functionality
  • 7.5.2 By Delivery Mode
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Functionality
  • 7.6.2 By Delivery Mode
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 IQVIA
  • 9.2.2 Accenture
  • 9.2.3 Cognizant
  • 9.2.4 Laboratory Corporation Of America Holdings
  • 9.2.5 IBM
  • 9.2.6 ArisGlobal
  • 9.2.7 ICON Plc
  • 9.2.8 Capgemini
  • 9.2.9 Oracle
  • 9.2.10 Parexel International Corporation